Global Bacteriophage Therapy Market Research Report 2024(Status and Outlook)
Report Overview
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report provides a deep insight into the global Bacteriophage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacteriophage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacteriophage Therapy market in any manner.
Global Bacteriophage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Market Segmentation (by Type)
Oral
Topical
Parenteral
Market Segmentation (by Application)
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bacteriophage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report provides a deep insight into the global Bacteriophage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacteriophage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacteriophage Therapy market in any manner.
Global Bacteriophage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Market Segmentation (by Type)
Oral
Topical
Parenteral
Market Segmentation (by Application)
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Bacteriophage Therapy Market
- Overview of the regional outlook of the Bacteriophage Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bacteriophage Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Bacteriophage Therapy
1.2 Key Market Segments
1.2.1 Bacteriophage Therapy Segment by Type
1.2.2 Bacteriophage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BACTERIOPHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Bacteriophage Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bacteriophage Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BACTERIOPHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Bacteriophage Therapy Sales by Manufacturers (2019-2024)
3.2 Global Bacteriophage Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bacteriophage Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bacteriophage Therapy Sales Sites, Area Served, Product Type
3.6 Bacteriophage Therapy Market Competitive Situation and Trends
3.6.1 Bacteriophage Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bacteriophage Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BACTERIOPHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Bacteriophage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BACTERIOPHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bacteriophage Therapy Sales Market Share by Type (2019-2024)
6.3 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Bacteriophage Therapy Price by Type (2019-2024)
7 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bacteriophage Therapy Market Sales by Application (2019-2024)
7.3 Global Bacteriophage Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
8 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Bacteriophage Therapy Sales by Region
8.1.1 Global Bacteriophage Therapy Sales by Region
8.1.2 Global Bacteriophage Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Bacteriophage Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bacteriophage Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bacteriophage Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bacteriophage Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bacteriophage Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Armata Pharmaceuticals, Inc.
9.1.1 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Basic Information
9.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Overview
9.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Market Performance
9.1.4 Armata Pharmaceuticals, Inc. Business Overview
9.1.5 Armata Pharmaceuticals, Inc. Bacteriophage Therapy SWOT Analysis
9.1.6 Armata Pharmaceuticals, Inc. Recent Developments
9.2 Eliava Biopreparations Ltd.
9.2.1 Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
9.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
9.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Market Performance
9.2.4 Eliava Biopreparations Ltd. Business Overview
9.2.5 Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
9.2.6 Eliava Biopreparations Ltd. Recent Developments
9.3 Pherecydes Pharma
9.3.1 Pherecydes Pharma Bacteriophage Therapy Basic Information
9.3.2 Pherecydes Pharma Bacteriophage Therapy Product Overview
9.3.3 Pherecydes Pharma Bacteriophage Therapy Product Market Performance
9.3.4 Pherecydes Pharma Bacteriophage Therapy SWOT Analysis
9.3.5 Pherecydes Pharma Business Overview
9.3.6 Pherecydes Pharma Recent Developments
9.4 Intralytix, Inc.
9.4.1 Intralytix, Inc. Bacteriophage Therapy Basic Information
9.4.2 Intralytix, Inc. Bacteriophage Therapy Product Overview
9.4.3 Intralytix, Inc. Bacteriophage Therapy Product Market Performance
9.4.4 Intralytix, Inc. Business Overview
9.4.5 Intralytix, Inc. Recent Developments
9.5 Phagelux Inc.
9.5.1 Phagelux Inc. Bacteriophage Therapy Basic Information
9.5.2 Phagelux Inc. Bacteriophage Therapy Product Overview
9.5.3 Phagelux Inc. Bacteriophage Therapy Product Market Performance
9.5.4 Phagelux Inc. Business Overview
9.5.5 Phagelux Inc. Recent Developments
9.6 Nextbiotics
9.6.1 Nextbiotics Bacteriophage Therapy Basic Information
9.6.2 Nextbiotics Bacteriophage Therapy Product Overview
9.6.3 Nextbiotics Bacteriophage Therapy Product Market Performance
9.6.4 Nextbiotics Business Overview
9.6.5 Nextbiotics Recent Developments
9.7 InnoPhage, Ltd
9.7.1 InnoPhage, Ltd Bacteriophage Therapy Basic Information
9.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Overview
9.7.3 InnoPhage, Ltd Bacteriophage Therapy Product Market Performance
9.7.4 InnoPhage, Ltd Business Overview
9.7.5 InnoPhage, Ltd Recent Developments
9.8 Locus Biosciences, Inc.
9.8.1 Locus Biosciences, Inc. Bacteriophage Therapy Basic Information
9.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Overview
9.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product Market Performance
9.8.4 Locus Biosciences, Inc. Business Overview
9.8.5 Locus Biosciences, Inc. Recent Developments
9.9 TechnoPhage
9.9.1 TechnoPhage Bacteriophage Therapy Basic Information
9.9.2 TechnoPhage Bacteriophage Therapy Product Overview
9.9.3 TechnoPhage Bacteriophage Therapy Product Market Performance
9.9.4 TechnoPhage Business Overview
9.9.5 TechnoPhage Recent Developments
9.10 Eligo Bioscience SA
9.10.1 Eligo Bioscience SA Bacteriophage Therapy Basic Information
9.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Overview
9.10.3 Eligo Bioscience SA Bacteriophage Therapy Product Market Performance
9.10.4 Eligo Bioscience SA Business Overview
9.10.5 Eligo Bioscience SA Recent Developments
9.11 Phagomed Biopharma GmbH.
9.11.1 Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
9.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
9.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Market Performance
9.11.4 Phagomed Biopharma GmbH. Business Overview
9.11.5 Phagomed Biopharma GmbH. Recent Developments
9.12 PhagePro, Inc.
9.12.1 PhagePro, Inc. Bacteriophage Therapy Basic Information
9.12.2 PhagePro, Inc. Bacteriophage Therapy Product Overview
9.12.3 PhagePro, Inc. Bacteriophage Therapy Product Market Performance
9.12.4 PhagePro, Inc. Business Overview
9.12.5 PhagePro, Inc. Recent Developments
9.13 Adaptive Phage Therapeutics, Inc.
9.13.1 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Basic Information
9.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Overview
9.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Market Performance
9.13.4 Adaptive Phage Therapeutics, Inc. Business Overview
9.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments
9.14 EnBiotix, Inc.
9.14.1 EnBiotix, Inc. Bacteriophage Therapy Basic Information
9.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Overview
9.14.3 EnBiotix, Inc. Bacteriophage Therapy Product Market Performance
9.14.4 EnBiotix, Inc. Business Overview
9.14.5 EnBiotix, Inc. Recent Developments
9.15 Intodeworld, Inc.
9.15.1 Intodeworld, Inc. Bacteriophage Therapy Basic Information
9.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Overview
9.15.3 Intodeworld, Inc. Bacteriophage Therapy Product Market Performance
9.15.4 Intodeworld, Inc. Business Overview
9.15.5 Intodeworld, Inc. Recent Developments
9.16 BiomX Ltd.
9.16.1 BiomX Ltd. Bacteriophage Therapy Basic Information
9.16.2 BiomX Ltd. Bacteriophage Therapy Product Overview
9.16.3 BiomX Ltd. Bacteriophage Therapy Product Market Performance
9.16.4 BiomX Ltd. Business Overview
9.16.5 BiomX Ltd. Recent Developments
9.17 Phi Therapeutics
9.17.1 Phi Therapeutics Bacteriophage Therapy Basic Information
9.17.2 Phi Therapeutics Bacteriophage Therapy Product Overview
9.17.3 Phi Therapeutics Bacteriophage Therapy Product Market Performance
9.17.4 Phi Therapeutics Business Overview
9.17.5 Phi Therapeutics Recent Developments
9.18 Fixed-phage Ltd.
9.18.1 Fixed-phage Ltd. Bacteriophage Therapy Basic Information
9.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Overview
9.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product Market Performance
9.18.4 Fixed-phage Ltd. Business Overview
9.18.5 Fixed-phage Ltd. Recent Developments
9.19 Micreos BV
9.19.1 Micreos BV Bacteriophage Therapy Basic Information
9.19.2 Micreos BV Bacteriophage Therapy Product Overview
9.19.3 Micreos BV Bacteriophage Therapy Product Market Performance
9.19.4 Micreos BV Business Overview
9.19.5 Micreos BV Recent Developments
9.20 ContraFect Corporation
9.20.1 ContraFect Corporation Bacteriophage Therapy Basic Information
9.20.2 ContraFect Corporation Bacteriophage Therapy Product Overview
9.20.3 ContraFect Corporation Bacteriophage Therapy Product Market Performance
9.20.4 ContraFect Corporation Business Overview
9.20.5 ContraFect Corporation Recent Developments
10 BACTERIOPHAGE THERAPY MARKET FORECAST BY REGION
10.1 Global Bacteriophage Therapy Market Size Forecast
10.2 Global Bacteriophage Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bacteriophage Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Bacteriophage Therapy Market Size Forecast by Region
10.2.4 South America Bacteriophage Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bacteriophage Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Bacteriophage Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bacteriophage Therapy by Type (2025-2030)
11.1.2 Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bacteriophage Therapy by Type (2025-2030)
11.2 Global Bacteriophage Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Bacteriophage Therapy Sales (K Units) Forecast by Application
11.2.2 Global Bacteriophage Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Bacteriophage Therapy
1.2 Key Market Segments
1.2.1 Bacteriophage Therapy Segment by Type
1.2.2 Bacteriophage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BACTERIOPHAGE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Bacteriophage Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bacteriophage Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BACTERIOPHAGE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Bacteriophage Therapy Sales by Manufacturers (2019-2024)
3.2 Global Bacteriophage Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bacteriophage Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bacteriophage Therapy Sales Sites, Area Served, Product Type
3.6 Bacteriophage Therapy Market Competitive Situation and Trends
3.6.1 Bacteriophage Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bacteriophage Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BACTERIOPHAGE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Bacteriophage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BACTERIOPHAGE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bacteriophage Therapy Sales Market Share by Type (2019-2024)
6.3 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Bacteriophage Therapy Price by Type (2019-2024)
7 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bacteriophage Therapy Market Sales by Application (2019-2024)
7.3 Global Bacteriophage Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
8 BACTERIOPHAGE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Bacteriophage Therapy Sales by Region
8.1.1 Global Bacteriophage Therapy Sales by Region
8.1.2 Global Bacteriophage Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Bacteriophage Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bacteriophage Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bacteriophage Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bacteriophage Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bacteriophage Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Armata Pharmaceuticals, Inc.
9.1.1 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Basic Information
9.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Overview
9.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Market Performance
9.1.4 Armata Pharmaceuticals, Inc. Business Overview
9.1.5 Armata Pharmaceuticals, Inc. Bacteriophage Therapy SWOT Analysis
9.1.6 Armata Pharmaceuticals, Inc. Recent Developments
9.2 Eliava Biopreparations Ltd.
9.2.1 Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
9.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
9.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Market Performance
9.2.4 Eliava Biopreparations Ltd. Business Overview
9.2.5 Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
9.2.6 Eliava Biopreparations Ltd. Recent Developments
9.3 Pherecydes Pharma
9.3.1 Pherecydes Pharma Bacteriophage Therapy Basic Information
9.3.2 Pherecydes Pharma Bacteriophage Therapy Product Overview
9.3.3 Pherecydes Pharma Bacteriophage Therapy Product Market Performance
9.3.4 Pherecydes Pharma Bacteriophage Therapy SWOT Analysis
9.3.5 Pherecydes Pharma Business Overview
9.3.6 Pherecydes Pharma Recent Developments
9.4 Intralytix, Inc.
9.4.1 Intralytix, Inc. Bacteriophage Therapy Basic Information
9.4.2 Intralytix, Inc. Bacteriophage Therapy Product Overview
9.4.3 Intralytix, Inc. Bacteriophage Therapy Product Market Performance
9.4.4 Intralytix, Inc. Business Overview
9.4.5 Intralytix, Inc. Recent Developments
9.5 Phagelux Inc.
9.5.1 Phagelux Inc. Bacteriophage Therapy Basic Information
9.5.2 Phagelux Inc. Bacteriophage Therapy Product Overview
9.5.3 Phagelux Inc. Bacteriophage Therapy Product Market Performance
9.5.4 Phagelux Inc. Business Overview
9.5.5 Phagelux Inc. Recent Developments
9.6 Nextbiotics
9.6.1 Nextbiotics Bacteriophage Therapy Basic Information
9.6.2 Nextbiotics Bacteriophage Therapy Product Overview
9.6.3 Nextbiotics Bacteriophage Therapy Product Market Performance
9.6.4 Nextbiotics Business Overview
9.6.5 Nextbiotics Recent Developments
9.7 InnoPhage, Ltd
9.7.1 InnoPhage, Ltd Bacteriophage Therapy Basic Information
9.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Overview
9.7.3 InnoPhage, Ltd Bacteriophage Therapy Product Market Performance
9.7.4 InnoPhage, Ltd Business Overview
9.7.5 InnoPhage, Ltd Recent Developments
9.8 Locus Biosciences, Inc.
9.8.1 Locus Biosciences, Inc. Bacteriophage Therapy Basic Information
9.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Overview
9.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Product Market Performance
9.8.4 Locus Biosciences, Inc. Business Overview
9.8.5 Locus Biosciences, Inc. Recent Developments
9.9 TechnoPhage
9.9.1 TechnoPhage Bacteriophage Therapy Basic Information
9.9.2 TechnoPhage Bacteriophage Therapy Product Overview
9.9.3 TechnoPhage Bacteriophage Therapy Product Market Performance
9.9.4 TechnoPhage Business Overview
9.9.5 TechnoPhage Recent Developments
9.10 Eligo Bioscience SA
9.10.1 Eligo Bioscience SA Bacteriophage Therapy Basic Information
9.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Overview
9.10.3 Eligo Bioscience SA Bacteriophage Therapy Product Market Performance
9.10.4 Eligo Bioscience SA Business Overview
9.10.5 Eligo Bioscience SA Recent Developments
9.11 Phagomed Biopharma GmbH.
9.11.1 Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
9.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
9.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Market Performance
9.11.4 Phagomed Biopharma GmbH. Business Overview
9.11.5 Phagomed Biopharma GmbH. Recent Developments
9.12 PhagePro, Inc.
9.12.1 PhagePro, Inc. Bacteriophage Therapy Basic Information
9.12.2 PhagePro, Inc. Bacteriophage Therapy Product Overview
9.12.3 PhagePro, Inc. Bacteriophage Therapy Product Market Performance
9.12.4 PhagePro, Inc. Business Overview
9.12.5 PhagePro, Inc. Recent Developments
9.13 Adaptive Phage Therapeutics, Inc.
9.13.1 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Basic Information
9.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Overview
9.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Market Performance
9.13.4 Adaptive Phage Therapeutics, Inc. Business Overview
9.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments
9.14 EnBiotix, Inc.
9.14.1 EnBiotix, Inc. Bacteriophage Therapy Basic Information
9.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Overview
9.14.3 EnBiotix, Inc. Bacteriophage Therapy Product Market Performance
9.14.4 EnBiotix, Inc. Business Overview
9.14.5 EnBiotix, Inc. Recent Developments
9.15 Intodeworld, Inc.
9.15.1 Intodeworld, Inc. Bacteriophage Therapy Basic Information
9.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Overview
9.15.3 Intodeworld, Inc. Bacteriophage Therapy Product Market Performance
9.15.4 Intodeworld, Inc. Business Overview
9.15.5 Intodeworld, Inc. Recent Developments
9.16 BiomX Ltd.
9.16.1 BiomX Ltd. Bacteriophage Therapy Basic Information
9.16.2 BiomX Ltd. Bacteriophage Therapy Product Overview
9.16.3 BiomX Ltd. Bacteriophage Therapy Product Market Performance
9.16.4 BiomX Ltd. Business Overview
9.16.5 BiomX Ltd. Recent Developments
9.17 Phi Therapeutics
9.17.1 Phi Therapeutics Bacteriophage Therapy Basic Information
9.17.2 Phi Therapeutics Bacteriophage Therapy Product Overview
9.17.3 Phi Therapeutics Bacteriophage Therapy Product Market Performance
9.17.4 Phi Therapeutics Business Overview
9.17.5 Phi Therapeutics Recent Developments
9.18 Fixed-phage Ltd.
9.18.1 Fixed-phage Ltd. Bacteriophage Therapy Basic Information
9.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Overview
9.18.3 Fixed-phage Ltd. Bacteriophage Therapy Product Market Performance
9.18.4 Fixed-phage Ltd. Business Overview
9.18.5 Fixed-phage Ltd. Recent Developments
9.19 Micreos BV
9.19.1 Micreos BV Bacteriophage Therapy Basic Information
9.19.2 Micreos BV Bacteriophage Therapy Product Overview
9.19.3 Micreos BV Bacteriophage Therapy Product Market Performance
9.19.4 Micreos BV Business Overview
9.19.5 Micreos BV Recent Developments
9.20 ContraFect Corporation
9.20.1 ContraFect Corporation Bacteriophage Therapy Basic Information
9.20.2 ContraFect Corporation Bacteriophage Therapy Product Overview
9.20.3 ContraFect Corporation Bacteriophage Therapy Product Market Performance
9.20.4 ContraFect Corporation Business Overview
9.20.5 ContraFect Corporation Recent Developments
10 BACTERIOPHAGE THERAPY MARKET FORECAST BY REGION
10.1 Global Bacteriophage Therapy Market Size Forecast
10.2 Global Bacteriophage Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bacteriophage Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Bacteriophage Therapy Market Size Forecast by Region
10.2.4 South America Bacteriophage Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bacteriophage Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Bacteriophage Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bacteriophage Therapy by Type (2025-2030)
11.1.2 Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bacteriophage Therapy by Type (2025-2030)
11.2 Global Bacteriophage Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Bacteriophage Therapy Sales (K Units) Forecast by Application
11.2.2 Global Bacteriophage Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bacteriophage Therapy Market Size Comparison by Region (M USD)
Table 5. Global Bacteriophage Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Bacteriophage Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bacteriophage Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bacteriophage Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2022)
Table 10. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bacteriophage Therapy Sales Sites and Area Served
Table 12. Manufacturers Bacteriophage Therapy Product Type
Table 13. Global Bacteriophage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bacteriophage Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bacteriophage Therapy Market Challenges
Table 22. Global Bacteriophage Therapy Sales by Type (K Units)
Table 23. Global Bacteriophage Therapy Market Size by Type (M USD)
Table 24. Global Bacteriophage Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Bacteriophage Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Bacteriophage Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Bacteriophage Therapy Market Size Share by Type (2019-2024)
Table 28. Global Bacteriophage Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Bacteriophage Therapy Sales (K Units) by Application
Table 30. Global Bacteriophage Therapy Market Size by Application
Table 31. Global Bacteriophage Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Bacteriophage Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Bacteriophage Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Bacteriophage Therapy Market Share by Application (2019-2024)
Table 35. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Bacteriophage Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Basic Information
Table 44. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Overview
Table 45. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Armata Pharmaceuticals, Inc. Business Overview
Table 47. Armata Pharmaceuticals, Inc. Bacteriophage Therapy SWOT Analysis
Table 48. Armata Pharmaceuticals, Inc. Recent Developments
Table 49. Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
Table 50. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
Table 51. Eliava Biopreparations Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Eliava Biopreparations Ltd. Business Overview
Table 53. Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
Table 54. Eliava Biopreparations Ltd. Recent Developments
Table 55. Pherecydes Pharma Bacteriophage Therapy Basic Information
Table 56. Pherecydes Pharma Bacteriophage Therapy Product Overview
Table 57. Pherecydes Pharma Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pherecydes Pharma Bacteriophage Therapy SWOT Analysis
Table 59. Pherecydes Pharma Business Overview
Table 60. Pherecydes Pharma Recent Developments
Table 61. Intralytix, Inc. Bacteriophage Therapy Basic Information
Table 62. Intralytix, Inc. Bacteriophage Therapy Product Overview
Table 63. Intralytix, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intralytix, Inc. Business Overview
Table 65. Intralytix, Inc. Recent Developments
Table 66. Phagelux Inc. Bacteriophage Therapy Basic Information
Table 67. Phagelux Inc. Bacteriophage Therapy Product Overview
Table 68. Phagelux Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Phagelux Inc. Business Overview
Table 70. Phagelux Inc. Recent Developments
Table 71. Nextbiotics Bacteriophage Therapy Basic Information
Table 72. Nextbiotics Bacteriophage Therapy Product Overview
Table 73. Nextbiotics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Nextbiotics Business Overview
Table 75. Nextbiotics Recent Developments
Table 76. InnoPhage, Ltd Bacteriophage Therapy Basic Information
Table 77. InnoPhage, Ltd Bacteriophage Therapy Product Overview
Table 78. InnoPhage, Ltd Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. InnoPhage, Ltd Business Overview
Table 80. InnoPhage, Ltd Recent Developments
Table 81. Locus Biosciences, Inc. Bacteriophage Therapy Basic Information
Table 82. Locus Biosciences, Inc. Bacteriophage Therapy Product Overview
Table 83. Locus Biosciences, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Locus Biosciences, Inc. Business Overview
Table 85. Locus Biosciences, Inc. Recent Developments
Table 86. TechnoPhage Bacteriophage Therapy Basic Information
Table 87. TechnoPhage Bacteriophage Therapy Product Overview
Table 88. TechnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. TechnoPhage Business Overview
Table 90. TechnoPhage Recent Developments
Table 91. Eligo Bioscience SA Bacteriophage Therapy Basic Information
Table 92. Eligo Bioscience SA Bacteriophage Therapy Product Overview
Table 93. Eligo Bioscience SA Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Eligo Bioscience SA Business Overview
Table 95. Eligo Bioscience SA Recent Developments
Table 96. Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
Table 97. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
Table 98. Phagomed Biopharma GmbH. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Phagomed Biopharma GmbH. Business Overview
Table 100. Phagomed Biopharma GmbH. Recent Developments
Table 101. PhagePro, Inc. Bacteriophage Therapy Basic Information
Table 102. PhagePro, Inc. Bacteriophage Therapy Product Overview
Table 103. PhagePro, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PhagePro, Inc. Business Overview
Table 105. PhagePro, Inc. Recent Developments
Table 106. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Basic Information
Table 107. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Overview
Table 108. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Adaptive Phage Therapeutics, Inc. Business Overview
Table 110. Adaptive Phage Therapeutics, Inc. Recent Developments
Table 111. EnBiotix, Inc. Bacteriophage Therapy Basic Information
Table 112. EnBiotix, Inc. Bacteriophage Therapy Product Overview
Table 113. EnBiotix, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. EnBiotix, Inc. Business Overview
Table 115. EnBiotix, Inc. Recent Developments
Table 116. Intodeworld, Inc. Bacteriophage Therapy Basic Information
Table 117. Intodeworld, Inc. Bacteriophage Therapy Product Overview
Table 118. Intodeworld, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Intodeworld, Inc. Business Overview
Table 120. Intodeworld, Inc. Recent Developments
Table 121. BiomX Ltd. Bacteriophage Therapy Basic Information
Table 122. BiomX Ltd. Bacteriophage Therapy Product Overview
Table 123. BiomX Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. BiomX Ltd. Business Overview
Table 125. BiomX Ltd. Recent Developments
Table 126. Phi Therapeutics Bacteriophage Therapy Basic Information
Table 127. Phi Therapeutics Bacteriophage Therapy Product Overview
Table 128. Phi Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Phi Therapeutics Business Overview
Table 130. Phi Therapeutics Recent Developments
Table 131. Fixed-phage Ltd. Bacteriophage Therapy Basic Information
Table 132. Fixed-phage Ltd. Bacteriophage Therapy Product Overview
Table 133. Fixed-phage Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Fixed-phage Ltd. Business Overview
Table 135. Fixed-phage Ltd. Recent Developments
Table 136. Micreos BV Bacteriophage Therapy Basic Information
Table 137. Micreos BV Bacteriophage Therapy Product Overview
Table 138. Micreos BV Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Micreos BV Business Overview
Table 140. Micreos BV Recent Developments
Table 141. ContraFect Corporation Bacteriophage Therapy Basic Information
Table 142. ContraFect Corporation Bacteriophage Therapy Product Overview
Table 143. ContraFect Corporation Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. ContraFect Corporation Business Overview
Table 145. ContraFect Corporation Recent Developments
Table 146. Global Bacteriophage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Bacteriophage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Bacteriophage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Bacteriophage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Bacteriophage Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Bacteriophage Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Bacteriophage Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Bacteriophage Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Bacteriophage Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bacteriophage Therapy Market Size Comparison by Region (M USD)
Table 5. Global Bacteriophage Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Bacteriophage Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bacteriophage Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bacteriophage Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2022)
Table 10. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bacteriophage Therapy Sales Sites and Area Served
Table 12. Manufacturers Bacteriophage Therapy Product Type
Table 13. Global Bacteriophage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bacteriophage Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bacteriophage Therapy Market Challenges
Table 22. Global Bacteriophage Therapy Sales by Type (K Units)
Table 23. Global Bacteriophage Therapy Market Size by Type (M USD)
Table 24. Global Bacteriophage Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Bacteriophage Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Bacteriophage Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Bacteriophage Therapy Market Size Share by Type (2019-2024)
Table 28. Global Bacteriophage Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Bacteriophage Therapy Sales (K Units) by Application
Table 30. Global Bacteriophage Therapy Market Size by Application
Table 31. Global Bacteriophage Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Bacteriophage Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Bacteriophage Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Bacteriophage Therapy Market Share by Application (2019-2024)
Table 35. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Bacteriophage Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Bacteriophage Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Bacteriophage Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Basic Information
Table 44. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Overview
Table 45. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Armata Pharmaceuticals, Inc. Business Overview
Table 47. Armata Pharmaceuticals, Inc. Bacteriophage Therapy SWOT Analysis
Table 48. Armata Pharmaceuticals, Inc. Recent Developments
Table 49. Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
Table 50. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
Table 51. Eliava Biopreparations Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Eliava Biopreparations Ltd. Business Overview
Table 53. Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
Table 54. Eliava Biopreparations Ltd. Recent Developments
Table 55. Pherecydes Pharma Bacteriophage Therapy Basic Information
Table 56. Pherecydes Pharma Bacteriophage Therapy Product Overview
Table 57. Pherecydes Pharma Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pherecydes Pharma Bacteriophage Therapy SWOT Analysis
Table 59. Pherecydes Pharma Business Overview
Table 60. Pherecydes Pharma Recent Developments
Table 61. Intralytix, Inc. Bacteriophage Therapy Basic Information
Table 62. Intralytix, Inc. Bacteriophage Therapy Product Overview
Table 63. Intralytix, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Intralytix, Inc. Business Overview
Table 65. Intralytix, Inc. Recent Developments
Table 66. Phagelux Inc. Bacteriophage Therapy Basic Information
Table 67. Phagelux Inc. Bacteriophage Therapy Product Overview
Table 68. Phagelux Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Phagelux Inc. Business Overview
Table 70. Phagelux Inc. Recent Developments
Table 71. Nextbiotics Bacteriophage Therapy Basic Information
Table 72. Nextbiotics Bacteriophage Therapy Product Overview
Table 73. Nextbiotics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Nextbiotics Business Overview
Table 75. Nextbiotics Recent Developments
Table 76. InnoPhage, Ltd Bacteriophage Therapy Basic Information
Table 77. InnoPhage, Ltd Bacteriophage Therapy Product Overview
Table 78. InnoPhage, Ltd Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. InnoPhage, Ltd Business Overview
Table 80. InnoPhage, Ltd Recent Developments
Table 81. Locus Biosciences, Inc. Bacteriophage Therapy Basic Information
Table 82. Locus Biosciences, Inc. Bacteriophage Therapy Product Overview
Table 83. Locus Biosciences, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Locus Biosciences, Inc. Business Overview
Table 85. Locus Biosciences, Inc. Recent Developments
Table 86. TechnoPhage Bacteriophage Therapy Basic Information
Table 87. TechnoPhage Bacteriophage Therapy Product Overview
Table 88. TechnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. TechnoPhage Business Overview
Table 90. TechnoPhage Recent Developments
Table 91. Eligo Bioscience SA Bacteriophage Therapy Basic Information
Table 92. Eligo Bioscience SA Bacteriophage Therapy Product Overview
Table 93. Eligo Bioscience SA Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Eligo Bioscience SA Business Overview
Table 95. Eligo Bioscience SA Recent Developments
Table 96. Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
Table 97. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
Table 98. Phagomed Biopharma GmbH. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Phagomed Biopharma GmbH. Business Overview
Table 100. Phagomed Biopharma GmbH. Recent Developments
Table 101. PhagePro, Inc. Bacteriophage Therapy Basic Information
Table 102. PhagePro, Inc. Bacteriophage Therapy Product Overview
Table 103. PhagePro, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. PhagePro, Inc. Business Overview
Table 105. PhagePro, Inc. Recent Developments
Table 106. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Basic Information
Table 107. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Overview
Table 108. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Adaptive Phage Therapeutics, Inc. Business Overview
Table 110. Adaptive Phage Therapeutics, Inc. Recent Developments
Table 111. EnBiotix, Inc. Bacteriophage Therapy Basic Information
Table 112. EnBiotix, Inc. Bacteriophage Therapy Product Overview
Table 113. EnBiotix, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. EnBiotix, Inc. Business Overview
Table 115. EnBiotix, Inc. Recent Developments
Table 116. Intodeworld, Inc. Bacteriophage Therapy Basic Information
Table 117. Intodeworld, Inc. Bacteriophage Therapy Product Overview
Table 118. Intodeworld, Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Intodeworld, Inc. Business Overview
Table 120. Intodeworld, Inc. Recent Developments
Table 121. BiomX Ltd. Bacteriophage Therapy Basic Information
Table 122. BiomX Ltd. Bacteriophage Therapy Product Overview
Table 123. BiomX Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. BiomX Ltd. Business Overview
Table 125. BiomX Ltd. Recent Developments
Table 126. Phi Therapeutics Bacteriophage Therapy Basic Information
Table 127. Phi Therapeutics Bacteriophage Therapy Product Overview
Table 128. Phi Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Phi Therapeutics Business Overview
Table 130. Phi Therapeutics Recent Developments
Table 131. Fixed-phage Ltd. Bacteriophage Therapy Basic Information
Table 132. Fixed-phage Ltd. Bacteriophage Therapy Product Overview
Table 133. Fixed-phage Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Fixed-phage Ltd. Business Overview
Table 135. Fixed-phage Ltd. Recent Developments
Table 136. Micreos BV Bacteriophage Therapy Basic Information
Table 137. Micreos BV Bacteriophage Therapy Product Overview
Table 138. Micreos BV Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Micreos BV Business Overview
Table 140. Micreos BV Recent Developments
Table 141. ContraFect Corporation Bacteriophage Therapy Basic Information
Table 142. ContraFect Corporation Bacteriophage Therapy Product Overview
Table 143. ContraFect Corporation Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. ContraFect Corporation Business Overview
Table 145. ContraFect Corporation Recent Developments
Table 146. Global Bacteriophage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Bacteriophage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Bacteriophage Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Bacteriophage Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Bacteriophage Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Bacteriophage Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Bacteriophage Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Bacteriophage Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Bacteriophage Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Bacteriophage Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Bacteriophage Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Bacteriophage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bacteriophage Therapy Market Size (M USD), 2019-2030
Figure 5. Global Bacteriophage Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Bacteriophage Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bacteriophage Therapy Market Size by Country (M USD)
Figure 11. Bacteriophage Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Bacteriophage Therapy Revenue Share by Manufacturers in 2023
Figure 13. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bacteriophage Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bacteriophage Therapy Market Share by Type
Figure 18. Sales Market Share of Bacteriophage Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Bacteriophage Therapy by Type in 2023
Figure 20. Market Size Share of Bacteriophage Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Bacteriophage Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bacteriophage Therapy Market Share by Application
Figure 24. Global Bacteriophage Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Bacteriophage Therapy Sales Market Share by Application in 2023
Figure 26. Global Bacteriophage Therapy Market Share by Application (2019-2024)
Figure 27. Global Bacteriophage Therapy Market Share by Application in 2023
Figure 28. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bacteriophage Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Bacteriophage Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Bacteriophage Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 37. Germany Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 44. China Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 50. South America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Bacteriophage Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Bacteriophage Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bacteriophage Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bacteriophage Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Bacteriophage Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Bacteriophage Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Bacteriophage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bacteriophage Therapy Market Size (M USD), 2019-2030
Figure 5. Global Bacteriophage Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Bacteriophage Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bacteriophage Therapy Market Size by Country (M USD)
Figure 11. Bacteriophage Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Bacteriophage Therapy Revenue Share by Manufacturers in 2023
Figure 13. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bacteriophage Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bacteriophage Therapy Market Share by Type
Figure 18. Sales Market Share of Bacteriophage Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Bacteriophage Therapy by Type in 2023
Figure 20. Market Size Share of Bacteriophage Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Bacteriophage Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bacteriophage Therapy Market Share by Application
Figure 24. Global Bacteriophage Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Bacteriophage Therapy Sales Market Share by Application in 2023
Figure 26. Global Bacteriophage Therapy Market Share by Application (2019-2024)
Figure 27. Global Bacteriophage Therapy Market Share by Application in 2023
Figure 28. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bacteriophage Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Bacteriophage Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Bacteriophage Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 37. Germany Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 44. China Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 50. South America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Bacteriophage Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Bacteriophage Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Bacteriophage Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bacteriophage Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bacteriophage Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Bacteriophage Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Bacteriophage Therapy Market Share Forecast by Application (2025-2030)
